emcure pharma ipo: all you need to know before investing
Published 13 days ago • 26K plays • Length 4:06Download video MP4
Download video MP3
Similar videos
-
20:11
emcure pharmaceuticals ipo: growth plans, existing profit & more | all you need to know
-
0:51
emcure pharma ipo good or bad to invest?
-
0:55
super sales india: all you need to know | ndtv profit
-
1:20
who's behind the 25,000 crore emcure pharmaceuticals heading for ipo? i emcure pharma ipo
-
1:15
what is disinvestment? | all you need to know on ndtv profit
-
1:31
strong debut for emcure pharma: lists at 31% premium
-
0:47
3 stocks to watch | ndtv profit
-
0:59
emcure pharma lists at 31% premium over ipo price, management to focus on emerging markets
-
7:37
emcure ipo | bansal ipo | listing day strategy | hold or sell ? | jayesh khatri
-
6:46
emcure pharma ipo lists at 30% premium | namita thapar & satish mehta share details | business news
-
39:25
live: namita thapar-backed emcure pharma ipo to debut on the bourses | ipo listing | n18l |cnbc tv18
-
0:53
emcure pharma ipo listing: shares debut at nearly 32% premium over ipo price | n18s | cnbc tv18
-
1:33
emcure pharmaceuticals ipo: satish mehta expands on biotech brands and upcoming products
-
2:19
emcure pharma makes a stellar debut, lists at 31% premium to issue price | cnbc tv18
-
9:14
listing strategy🔥emcure pharma ipo allotment hold or sell | bansal wire ipo latest gmp
-
5:44
emcure pharma ipo launch: what to expect? market expert sneha poddar analysis the ipo debut
-
4:31
which funds should you choose for a rs 2000 sip? | the mutual fund show
-
8:01
post listing strategy🔥emcure pharma ipo allotment hold or sell | big mutual fund bulk deal
-
5:08
emcure pharma ipo: namita thappar on tie up with sanofi & in-house products for cardiac segment